Open Trial of Duloxetine in Outpatients With Irritable Bowel Syndrome Symptoms and Co-Morbid Major Depression
Phase of Trial: Phase IV
Latest Information Update: 28 Nov 2016
At a glance
- Drugs Duloxetine (Primary)
- Indications Irritable bowel syndrome; Major depressive disorder
- Focus Therapeutic Use
- 19 Nov 2016 Results of preliminary analysis published in the Journal of Clinical Psychopharmacology.
- 23 Mar 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 19 Aug 2013 Planned end date changed from 1 Dec 2012 to 1 Dec 2014 as reported by ClinicalTrials.gov.